Literature DB >> 19406940

Computational and functional analysis of growth hormone (GH)-regulated genes identifies the transcriptional repressor B-cell lymphoma 6 (Bc16) as a participant in GH-regulated transcription.

Yili Chen1, Grace Lin, Jeffrey S Huo, Deborah Barney, Zhenni Wang, Tamara Livshiz, David J States, Zhaohui S Qin, Jessica Schwartz.   

Abstract

For insight into transcriptional mechanisms mediating physiological responses to GH, data mining was performed on a profile of GH-regulated genes induced or inhibited at different times in highly responsive 3T3-F442A adipocytes. Gene set enrichment analysis indicated that GH-regulated genes are enriched in pathways including phosphoinositide and insulin signaling and suggested that suppressor of cytokine signaling 2 (SOCS2) and phosphoinositide 3' kinase regulatory subunit p85alpha (Pik3r1) are important targets. Model-based Chinese restaurant clustering identified a group of genes highly regulated by GH at times consistent with its key physiological actions. This cluster included IGF-I, phosphoinositide 3' kinase p85alpha, SOCS2, and cytokine-inducible SH2-containing protein. It also contains the most strongly repressed gene in the profile, B cell lymphoma 6 (Bcl6), a transcriptional repressor. Quantitative real-time PCR verified the strong decrease in Bcl6 mRNA after GH treatment and induction of the other genes in the cluster. Transcriptional network analysis of the genes implicated signal transducer and activator of transcription (Stat) 5 as hub regulating the most responsive genes, Igf1, Socs2, Cish, and Bcl6. Transcriptional activation analysis demonstrated that Bcl6 inhibits SOCS2-luciferase and blunts its stimulation by GH. Occupancy of endogenous Bcl6 on SOCS2 DNA decreased after GH treatment, whereas occupancy of Stat5 increased concomitantly. Thus, GH-mediated inhibition of Bcl6 expression may reverse the repression of SOCS2 and facilitate SOCS2 activation by GH. Together these analyses identify Bcl6 as a participant in GH-regulated gene expression and suggest an interplay between the repressor Bcl6 and the activator Stat5 in regulating genes, which contribute to GH responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19406940      PMCID: PMC2717871          DOI: 10.1210/en.2009-0212

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  72 in total

1.  STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression.

Authors:  Ferenc A Scheeren; Marianne Naspetti; Sean Diehl; Remko Schotte; Maho Nagasawa; Erwin Wijnands; Ramon Gimeno; Florry A Vyth-Dreese; Bianca Blom; Hergen Spits
Journal:  Nat Immunol       Date:  2005-02-13       Impact factor: 25.606

2.  Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARalpha, and BCL-6.

Authors:  C W Wong; M L Privalsky
Journal:  J Biol Chem       Date:  1998-10-16       Impact factor: 5.157

3.  The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.

Authors:  K D Huynh; V J Bardwell
Journal:  Oncogene       Date:  1998-11-12       Impact factor: 9.867

4.  Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein.

Authors:  P Dhordain; O Albagli; R J Lin; S Ansieau; S Quief; A Leutz; J P Kerckaert; R M Evans; D Leprince
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

5.  Transcriptional repression of Stat6-dependent interleukin-4-induced genes by BCL-6: specific regulation of iepsilon transcription and immunoglobulin E switching.

Authors:  M B Harris; C C Chang; M T Berton; N N Danial; J Zhang; D Kuehner; B H Ye; M Kvatyuk; P P Pandolfi; G Cattoretti; R Dalla-Favera; P B Rothman
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

6.  Growth hormone regulation of SOCS-2, SOCS-3, and CIS messenger ribonucleic acid expression in the rat.

Authors:  P Tollet-Egnell; A Flores-Morales; A Stavréus-Evers; L Sahlin; G Norstedt
Journal:  Endocrinology       Date:  1999-08       Impact factor: 4.736

Review 7.  Role of SOCS2 in growth hormone actions.

Authors:  Ann M Turnley
Journal:  Trends Endocrinol Metab       Date:  2005-03       Impact factor: 12.015

8.  Isolation of unique STAT5 targets by chromatin immunoprecipitation-based gene identification.

Authors:  Erik A Nelson; Sarah R Walker; James V Alvarez; David A Frank
Journal:  J Biol Chem       Date:  2004-10-20       Impact factor: 5.157

9.  Cyclic AMP potentiates growth hormone-dependent differentiation of 3T3-F442A preadipocytes: possible involvement of the transcription factor CREB.

Authors:  S J Yarwood; E Kilgour; N G Anderson
Journal:  Mol Cell Endocrinol       Date:  1998-03-16       Impact factor: 4.102

10.  Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor.

Authors:  H Niu; B H Ye; R Dalla-Favera
Journal:  Genes Dev       Date:  1998-07-01       Impact factor: 11.361

View more
  21 in total

Review 1.  Mapping the growth hormone--Stat5b--IGF-I transcriptional circuit.

Authors:  Peter Rotwein
Journal:  Trends Endocrinol Metab       Date:  2012-02-21       Impact factor: 12.015

2.  Dynamic, sex-differential STAT5 and BCL6 binding to sex-biased, growth hormone-regulated genes in adult mouse liver.

Authors:  Yijing Zhang; Ekaterina V Laz; David J Waxman
Journal:  Mol Cell Biol       Date:  2011-12-12       Impact factor: 4.272

3.  Defining the epigenetic actions of growth hormone: acute chromatin changes accompany GH-activated gene transcription.

Authors:  Dennis J Chia; Peter Rotwein
Journal:  Mol Endocrinol       Date:  2010-08-11

4.  C/EBPβ mediates growth hormone-regulated expression of multiple target genes.

Authors:  Tracy X Cui; Grace Lin; Christopher R LaPensee; Anda-Alexandra Calinescu; Maanjot Rathore; Cale Streeter; Graciela Piwien-Pilipuk; Nathan Lanning; Hui Jin; Christin Carter-Su; Zhaohui S Qin; Jessica Schwartz
Journal:  Mol Endocrinol       Date:  2011-02-03

5.  GH/STAT5 signaling during the growth period in livers of mice overexpressing GH.

Authors:  Carolina S Martinez; Verónica G Piazza; María E Díaz; Ravneet K Boparai; Oge Arum; María C Ramírez; Lorena González; Damasia Becú-Villalobos; Andrzej Bartke; Daniel Turyn; Johanna G Miquet; Ana I Sotelo
Journal:  J Mol Endocrinol       Date:  2015-02-17       Impact factor: 5.098

6.  Cross Talk Between GH-Regulated Transcription Factors HNF6 and CUX2 in Adult Mouse Liver.

Authors:  Tara L Conforto; George F Steinhardt; David J Waxman
Journal:  Mol Endocrinol       Date:  2015-07-28

7.  Reciprocal occupancy of BCL6 and STAT5 on Growth Hormone target genes: contrasting transcriptional outcomes and promoter-specific roles of p300 and HDAC3.

Authors:  Grace Lin; Christopher R LaPensee; Zhaohui S Qin; Jessica Schwartz
Journal:  Mol Cell Endocrinol       Date:  2014-08-01       Impact factor: 4.102

8.  BCL6 controls Th9 cell development by repressing Il9 transcription.

Authors:  Ribal Bassil; William Orent; Marta Olah; Ahmed T Kurdi; Michael Frangieh; Thomas Buttrick; Samia J Khoury; Wassim Elyaman
Journal:  J Immunol       Date:  2014-05-30       Impact factor: 5.422

Review 9.  Minireview: mechanisms of growth hormone-mediated gene regulation.

Authors:  Dennis J Chia
Journal:  Mol Endocrinol       Date:  2014-05-13

10.  Male-specific hepatic Bcl6: growth hormone-induced block of transcription elongation in females and binding to target genes inversely coordinated with STAT5.

Authors:  Rosana D Meyer; Ekaterina V Laz; Ting Su; David J Waxman
Journal:  Mol Endocrinol       Date:  2009-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.